Trial intelligence / Profile preview

Bioequivalence study of dienogest 2 mg tablets in healthy Thai female volunteers under fasting conditions

TCTR20240320004Phase 1Unknown

Sponsor
Bio-innova
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of dienogest (2 arms), sponsored by Bio-innova. Status: unknown.

02

Drugs

dienogest

Beyond the preview

Go deeper on TCTR20240320004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240320004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call